Biontech revenue 5308 million euros Q2 2021 -EPS 10,77 euros

The German pharma company Biontech have published its Q2 figures. According to the release, company revenue increased to 5308 million euros during q2 2021 compared to 41,7 million euros year ago.

Biontech, together with Pfizer, have shipped over one billion doses of Covid-vaccines worldwide and according to the CEO Ugur Sahin the companies have now expanded the supply to low and middle-income countries.

Net profit increased to 2787 million euros from 88,3 million euros loss year ago. EPS was 10,77 euros compared to 0,38 euros loss year ago.

The Pfizer-Biontech covid-vaccine is 91,2 % effective against Covid measured seven days through up to six months after the second dose.

The company is planning to submit new data to the US, EU and other pharma regulators in the coming weeks. The companies have for example studied the effect if the vaccine targets the full spike protein.

Biontech estimates that they will manufacture three billion doses of the vaccine by the end of this year and have the capacity to manufacture up to four billion doses in 2022.

The R&D expenses increased to 201 million euros from 95 million euros. The whole year R&D expenses this year are expected to be around one billion euros.

Berkshire Hathaway earnings up 21 % in Q2 2021

The US Berkshire Hathaway said its earnings increased by 21 % to 6,69 billion dollars during the second quarter 2021. Year ago the level was 5,51 billion dollars.

Overall earnings with investments increased 6,8% to 28 billion dollars during the period. The Cash amounted 144 billion dollars at the end of the quarter.

One of the growth sectors were the company railroads which earnings increased by 27% to 2,26 billion dollars.

The company said that risk from the covid-pandemic still  remains and could impact the future results.

Moderna: Covid-efficacy 93% for six months after second dose

The US pharma company Moderna (MRNA) said that final Phase 3 studies show that their covid-vaccine efficacy remains durable through six months after second dose.

Moderna also stated that covid booster candidates shows robust antibody response to covid-variants.

Moderna’s revenue was 4,4 billion dollars during the second quarter, ending June 30. Year ago revenue was 67 million dollars.

Net income increased to 2,8 billion dollars during the quarter compared to 117 million loss year ago. EPS increased to 6,46 dollars from 0,31 dollars loss.

Moderna said its vision is to make a single annual dose that provides protection against covid-19, flu and RSV for adults. It is having mRMA candidates in clinical trials across five therapeutic areas including infections diseases, cardiovascular, oncology, rare diseases and autoimmune disorders.

Moderna’s stock was included into S&P 500 index in July 21st. Yesterday Moderna’s stock (MRNA) closed to 416,26 dollars, down 0,67% in New York.

Pfizer’s revenue 19 billion in Q2 2021- raises full year guidance

The US pharma company Pfizer has published its Q2 2021 figures. According to Pfizer the revenue increased to nearly 19 billion dollars, growth nearly 90%.

-The second quarter was remarkable in a number of ways. Most visible the speed and efficiency of our efforts with Biontech, to help vaccinate the world against Covid-19 have been unprecedented with now more than a billion doses of vaccines have been delivered globally, said CEO Albert Bourla in the release.

Pfizer’s net income increased 59% to 5,5 billion dollars. During the period R&D expenses were up 17% to 2,3 billion dollars.

Pfizer Biontech covid-vaccine showed 7,8 billion dollars in direct sales and revenues during the quarter.

The EPS was 0,98 dollars and the whole year estimate is raised to 3,95-4,04 dollars.

The Company expects to manufacture 3 billion covid-doses by the end of the year.

Tesla total revenues 11,9 billion dollars Q2 2021

The US electric car manufacturer Tesla ( TSLA) reported total revenues of 11,9 billion dollars during Q2 2021. Operating margin was 11% when it was 5,7% during the first quarter 2021.

Automotive revenue was 10,2 billion dollars when it was 9 billion dollars in the previous quarter. Regulatory credits were 354 million compared to 518 million earlier.

Tesla produced 206.421 vehicles, of which were Model S/X 2340 and Model 3/Y 204.081. According to Tesla Model Y production is estimated to start in Berlin and in Austin this year. Semi truck production is planned för 2022. Tesla said it is making progress with Cybertruck.